Related references
Note: Only part of the references are listed.Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Carbapenem Resistance Among Klebsiella pneumoniae Isolates: Risk Factors, Molecular Characteristics, and Susceptibility Patterns
Khetam Hussein et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Gopi Patel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality
Mitchell J. Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Ongoing epidemic of bla(VIM-1)-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey
M. Psichogiou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections:: a matched case-control study
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients
YG Kwak et al.
MICROBIAL DRUG RESISTANCE (2005)
Metallo-β-lactamases:: the quiet before the storm?
TR Walsh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review
AD Harris et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
